JACQUELINE DEWITT: Open Payments
NPI 1316532559 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,758 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,758
Food & beverage: $1,758
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $367 |
| AstraZeneca Pharmaceuticals LP | 3 | $322 |
| ABBVIE INC. | 2 | $249 |
| Lilly USA, LLC | 2 | $241 |
| Phathom Pharmaceuticals, Inc. | 2 | $168 |
| Madrigal Pharmaceuticals | 1 | $121 |
| Gilead Sciences, Inc. | 1 | $107 |
| Amgen Inc. | 1 | $78 |
| Novo Nordisk Inc | 1 | $66 |
| PFIZER INC. | 1 | $40 |
Products named: DUPIXENT, VRAYLAR, AIRSUPRA, VOQUEZNA, ZEPBOUND, REZDIFFRA, MOUNJARO, Epclusa.
Industry payments across TX — which companies pay providers there.
